Clinical Drug Experience Knowledgebase

Acromegaly (Phase 2)

Acute Disease (Phase 2)

Alzheimer Disease (Phase 2)

Amyloid Neuropathies (Phase 3)

Amyloid Neuropathies, Familial (Phase 3)

Amyloidosis (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 1)

Angioedema (Phase 2)

Angioedemas, Hereditary (Phase 2)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Atrial Fibrillation (Phase 2)

Atrophy (Phase 2)

beta-Thalassemia (Phase 2)

Bronchitis (Phase 2)

Bronchitis, Chronic (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cardiomyopathies (Phase 3)

Cardiovascular Abnormalities (Phase 1)

Cardiovascular Diseases (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Congenital Abnormalities (Phase 3)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Crohn Disease (Phase 3)

Cystic Fibrosis (Phase 1)

Cytomegalovirus Retinitis (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Disease (Phase 3)

Dyslipidemias (Phase 3)

Fatty Liver (Phase 2)

Fibrosis (Phase 1)

Genetic Diseases, Inborn (Phase 3)

Geographic Atrophy (Phase 2)

Glomerulonephritis, IGA (Phase 2)

Heart Diseases (Phase 3)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Huntington Disease (Phase 2)

Hypercholesterolemia (Phase 3)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hyperlipoproteinemia Type I (Phase 3)

Hyperlipoproteinemia Type II (Phase 3)

Hypertension (Phase 2)

Hypertriglyceridemia (Phase 3)

Hypobetalipoproteinemias (Phase 2)

Hypolipoproteinemias (Phase 2)

Infant, Newborn, Diseases (Phase 3)

Insulin Resistance (Phase 2)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Lipid Metabolism Disorders (Phase 3)

Lipid Metabolism, Inborn Errors (Phase 3)

Lipodystrophy (Phase 3)

Lipodystrophy, Familial Partial (Phase 3)

Liver Diseases (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Lung Neoplasms (Phase 3)

Macular Degeneration (Phase 2)

Metabolic Diseases (Phase 3)

Metabolism, Inborn Errors (Phase 3)

Migraine Disorders (Phase 2)

Motor Neuron Disease (Phase 1)

Multiple Myeloma (Phase 1)

Myocardial Ischemia (Phase 3)

Myotonic Dystrophy (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 2)

Obesity (Phase 2)

Pancreatic Neoplasms (Phase 2)

Parkinson Disease (Phase 1)

Polyneuropathies (Phase 3)

Prostatic Neoplasms (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Renal Insufficiency (Phase 1)

Retinitis (Phase 2)

Sclerosis (Phase 1)

Syndrome (Phase 3)

Thalassemia (Phase 2)

Thromboembolism (Phase 2)

Ulcer (Phase 2)

Venous Thromboembolism (Phase 2)